vs
Side-by-side financial comparison of BCB BANCORP INC (BCBP) and STEM, INC. (STEM). Click either name above to swap in a different company.
STEM, INC. is the larger business by last-quarter revenue ($47.1M vs $26.2M, roughly 1.8× BCB BANCORP INC). STEM, INC. runs the higher net margin — -33.9% vs -49.7%, a 15.8% gap on every dollar of revenue. On growth, BCB BANCORP INC posted the faster year-over-year revenue change (13.1% vs -15.6%). Over the past eight quarters, STEM, INC.'s revenue compounded faster (36.1% CAGR vs 1.8%).
StemCells, Inc. is a public biopharmaceutical company headquartered in Newark, California, that is developing purified human neural stem cells (HuCNS-SCs) in the hopes of treating central nervous system disorders and paralysis. StemCells' HuCNS-SCs have the ability to differentiate into the three main types of cells found in the central nervous system: neurons, astrocytes and oligodendrocytes.
BCBP vs STEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $26.2M | $47.1M |
| Net Profit | $-12.0M | $-16.0M |
| Gross Margin | — | 48.9% |
| Operating Margin | -71.9% | -17.7% |
| Net Margin | -49.7% | -33.9% |
| Revenue YoY | 13.1% | -15.6% |
| Net Profit YoY | -467.6% | 68.8% |
| EPS (diluted) | $-0.73 | $-4.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $26.2M | $47.1M | ||
| Q3 25 | $26.5M | $38.2M | ||
| Q2 25 | $25.2M | $38.4M | ||
| Q1 25 | $23.8M | $32.5M | ||
| Q4 24 | $23.1M | $55.8M | ||
| Q3 24 | $26.2M | $29.3M | ||
| Q2 24 | $20.4M | $34.0M | ||
| Q1 24 | $25.3M | $25.5M |
| Q4 25 | $-12.0M | $-16.0M | ||
| Q3 25 | $4.3M | $-23.8M | ||
| Q2 25 | $3.6M | $202.5M | ||
| Q1 25 | $-8.3M | $-25.0M | ||
| Q4 24 | $3.3M | $-51.1M | ||
| Q3 24 | $6.7M | $-148.3M | ||
| Q2 24 | $2.8M | $-582.3M | ||
| Q1 24 | $5.9M | $-72.3M |
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% | ||
| Q1 24 | — | -95.0% |
| Q4 25 | -71.9% | -17.7% | ||
| Q3 25 | 21.9% | -33.6% | ||
| Q2 25 | 19.9% | -34.8% | ||
| Q1 25 | -49.2% | -65.0% | ||
| Q4 24 | 19.9% | -84.4% | ||
| Q3 24 | 35.7% | -493.2% | ||
| Q2 24 | 19.5% | -1705.5% | ||
| Q1 24 | 33.0% | -267.0% |
| Q4 25 | -49.7% | -33.9% | ||
| Q3 25 | 16.1% | -62.2% | ||
| Q2 25 | 14.2% | 527.8% | ||
| Q1 25 | -35.0% | -76.9% | ||
| Q4 24 | 14.1% | -91.6% | ||
| Q3 24 | 25.5% | -506.3% | ||
| Q2 24 | 13.8% | -1712.6% | ||
| Q1 24 | 23.2% | -283.9% |
| Q4 25 | $-0.73 | $-4.40 | ||
| Q3 25 | $0.22 | $-2.84 | ||
| Q2 25 | $0.18 | $-1.79 | ||
| Q1 25 | $-0.51 | $-0.15 | ||
| Q4 24 | $0.17 | $-15.29 | ||
| Q3 24 | $0.36 | $-18.24 | ||
| Q2 24 | $0.14 | $-71.81 | ||
| Q1 24 | $0.32 | $-0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $48.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $304.3M | $-249.4M |
| Total Assets | $3.3B | $308.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | — | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M | ||
| Q1 24 | — | $112.8M |
| Q4 25 | $304.3M | $-249.4M | ||
| Q3 25 | $318.5M | $-235.7M | ||
| Q2 25 | $315.7M | $-214.1M | ||
| Q1 25 | $314.7M | $-417.5M | ||
| Q4 24 | $323.9M | $-398.4M | ||
| Q3 24 | $328.1M | $-344.1M | ||
| Q2 24 | $320.7M | $-203.2M | ||
| Q1 24 | $320.1M | $371.6M |
| Q4 25 | $3.3B | $308.9M | ||
| Q3 25 | $3.4B | $362.6M | ||
| Q2 25 | $3.4B | $379.2M | ||
| Q1 25 | $3.5B | $405.1M | ||
| Q4 24 | $3.6B | $437.4M | ||
| Q3 24 | $3.6B | $537.8M | ||
| Q2 24 | $3.8B | $691.5M | ||
| Q1 24 | $3.8B | $1.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $35.9M | $8.2M |
| Free Cash FlowOCF − Capex | $34.9M | — |
| FCF MarginFCF / Revenue | 133.3% | — |
| Capex IntensityCapex / Revenue | 4.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $58.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $35.9M | $8.2M | ||
| Q3 25 | $8.7M | $11.4M | ||
| Q2 25 | $10.3M | $-21.3M | ||
| Q1 25 | $5.0M | $8.5M | ||
| Q4 24 | $67.7M | $-14.7M | ||
| Q3 24 | $43.5M | $-9.4M | ||
| Q2 24 | $8.1M | $-11.9M | ||
| Q1 24 | $8.3M | $-621.0K |
| Q4 25 | $34.9M | — | ||
| Q3 25 | $8.5M | — | ||
| Q2 25 | $10.2M | — | ||
| Q1 25 | $4.7M | — | ||
| Q4 24 | $66.5M | — | ||
| Q3 24 | $43.4M | — | ||
| Q2 24 | $8.1M | — | ||
| Q1 24 | $8.1M | — |
| Q4 25 | 133.3% | — | ||
| Q3 25 | 32.0% | — | ||
| Q2 25 | 40.4% | — | ||
| Q1 25 | 19.8% | — | ||
| Q4 24 | 287.5% | — | ||
| Q3 24 | 166.0% | — | ||
| Q2 24 | 39.6% | — | ||
| Q1 24 | 32.3% | — |
| Q4 25 | 4.0% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 1.2% | — | ||
| Q4 24 | 5.3% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.05× | — | ||
| Q2 25 | 2.90× | -0.11× | ||
| Q1 25 | — | — | ||
| Q4 24 | 20.70× | — | ||
| Q3 24 | 6.53× | — | ||
| Q2 24 | 2.88× | — | ||
| Q1 24 | 1.41× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
